Effect of 1110 MBq Radioiodine in Reducing Thyroid Volume in Multinodular Goiter: A New Protocol
Author(s) -
Armando Flores-Rebollar,
Aída Ruiz-Juvera,
Guadalupe López-Carrasco,
Ofelia González-Treviño
Publication year - 2013
Publication title -
journal of clinical medicine research
Language(s) - English
Resource type - Journals
eISSN - 1918-3011
pISSN - 1918-3003
DOI - 10.4021/jocmr1361w
Subject(s) - medicine , multinodular goiter , goiter , protocol (science) , thyroid , nuclear medicine , volume (thermodynamics) , medical physics , radiochemistry , pathology , chemistry , physics , alternative medicine , quantum mechanics
There is no consensus on the optimal treatment of multinodular goiter (MNG), but in the past few years, the use of radioiodine has increased. This study's objective was to evaluate adjuvant methimazole (MMI) therapy to increase and standardize radioiodine uptake (RAIU) with a fixed therapeutic (131)I dose of 1110 MBq (30 mCi).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom